Baclofen

Related products

• 

  Early onset Parkinson's disease , Spinocerebellar ataxia

  Levodopa

  【Product name】Duodopa, NEODOPASTON, MADOPAR, STALEVO, EC-DOPARL, Rytary, DOPASTON, Sinemet

  [English common name]L-DOPA

  [Chinese common name]Levodopa

  [English name]

  [Chinese other name]

  [indications]
  Carbidopa / levodopa tablets: This product is used forParkinson's diseaseSymptomatic Parkinson's Syndrome (arteriosclerosis or toxicity after encephalitis), but does not include Parkinson's syndrome caused by drugs.
  Levodopa / benserazide hydrochloride compound tablets: Parkinson's disease, Parkinson's syndrome
  Compound Levodopa/Carbidopa Gut Gel: A sufficient effect, an improvement in the daily variation of symptoms, does not result in the availability of existing drug therapies in Parkinson's disease, including the formulation of levodopa.

  【Dosage】
  Carbidopa / levodopa tablets: Oral: start 137.5mg each time, 3 times a day, increase 137.5mg daily, until 2.2g per day. The maintenance dose is 550 mg per day for 20 to 40 weeks. Controlled-release tablets: mild to moderate patients, starting dose of 250mg each time, 2 to 3 times a day, gradually increasing the dose, most patients only need 2 to 8 tablets per day, taking fractions. Levodopa was discontinued 8 hours prior to the start of dosing.
  Levodopa / benserazide hydrochloride compound tablets: no levodopa
  Adults: daily dose 1-3 capsules for the first 1-3 times, gradually taking 1-2 tablets per day for oral administration after meals, increasing every 2-3 days, 3-6 tablets once a day as a maintenance dose Oral administration. In addition, the increase or decrease depends on the age and symptoms of the patient.
  Used levodopa
  Adult: The initial daily dose is switched to the amount of levodopa (each tablet is contained in levodopa 100 mg), which is administered orally at a dose of 1-3, gradually increasing or decreasing, 3 to 6 The tablets are administered orally as a daily dose of a maintenance dose.
  In addition, the increase or decrease depends on the age and symptoms of the patient.
  Compound levodopa/carbidopa enteric gel: This agent is administered directly to the oral administration of levodopa before administration through the gastrostomy. The initial dose is divided into administration and continuous morning administration.
  The dose in the lower dose range is then adjusted by the condition of the patient. In addition, additional management is performed as needed during continuous dosing.
  For adults, administration of 10 to 30 minutes (100/25-200/50 mg levodopa/carbidopa hydrate) 5-10 ml, if administered in the morning, 2-6 ml / time (levodopa / After the carbidopa water is applied at 40/10-120/30 mg/time, it is a hydrate. Maximum management time of 16 days a day. An additional dose of each doubling and 0.5-2.0 ml (10/2.5-40/10 mg levodopa/carbidopa hydrate).
  The dose of this agent will be adjusted according to the symptoms, administrative morning 15 ml (300/75 mg levodopa / carbidopa hydrate), continuous administration is 200/50 mg / time 10 ml / time (left-handed Ba / Carbidopa hydrate) It is not more than something. In addition, the total daily dose does not exceed the larger of 100 ml (2000/500 mg levodopa / carbidopa hydrate).

  [Storage]
  Carbidopa / levodopa tablets: sealed
  Levodopa / benserazide hydrochloride compound tablets: sealed
  Compound levodopa/carbidopa enteric gel: sealed

  [Tips] Some of the information on this site comes from the Internet and is only used internally by pharmacists or medical staff. It is not a substitute for doctors to diagnose face to face. Please consult a professional pharmacist for specific medications. Please refer to the actual product manual or the actual product for the product content.
• 

  Parkinson , Spinocerebellar ataxia

  Amantadine

  【Product name】Amantadine

  [English common name]Amantadine

  [Chinese common name]Amantadine

  [English name]1-Adamantanamine, 1-Aminoadamantane

  [Chinese other name]1-adamantanamine, 1-amine fundane

  [indications]
  Amantadine capsules:
  1. It has obvious curative effect on tremor palsy, relieves tremor and stiffness, and has quick onset effect. It has obvious effect 48 hours after administration and reaches peak after 2 weeks. The drug is excreted in the original form by the kidney, and the acid urinary excretion is accelerated.
  2. The anti-Asian A-II influenza virus has a protective rate of about 70% for contacts with this type of influenza.
  3. Antipyretic effect is effective for a variety of inflammation, sepsis, viral pneumonia, etc. If combined with antibiotics, antipyretic effect is better than antibiotics alone.
  Amantadine hydrochloride tablets: This product is used forParkinson's DiseaseParkinson's syndrome, drug-induced extrapyramidal disease, Parkinson's syndrome after carbon monoxide poisoning, and Parkinson's syndrome with cerebral arteriosclerosis in the elderly. It is also used to prevent respiratory infections caused by influenza A virus.
  Amantadine hydrochloride capsule: This product is used for Parkinson's disease, Parkinson's syndrome, drug-induced extrapyramidal disease, Parkinson's syndrome after carbon monoxide poisoning and Parkinson's syndrome with cerebral arteriosclerosis in the elderly. It is also used to prevent respiratory infections caused by influenza A virus.
  Amantadine hydrochloride granules: used to prevent and treat respiratory tract infections caused by influenza A virus. This product, when combined with the inactivated influenza A vaccine, promotes the production of prophylactic antibodies.
  Compound amantadine hydrochloride tablets: used for prevention, treatment of influenza, high fever caused by other causes, also has a good antipyretic effect.
  Compound amantadine aminopyrine tablets: used for colds caused by fever, headache, stuffy nose, sneezing, runny nose, limb soreness, etc., also have a good effect on high fever caused by other causes.

  【Dosage】
  Amantadine capsules:
  Oral: 0.1g per adult, 1 in the morning and evening, the maximum dose is 400mg per day. The dosage of children can be reduced by 3 to 5 days, up to 10 days. Children from 1 to 9 years old, 3 mg per kilogram of body weight per day, the maximum dosage is no more than 150 mg per day. Any questions, please follow the doctor's advice!
  Amantadine hydrochloride tablets: administered orally.
  Adult
  (1) Parkinson's disease, Parkinson's syndrome, once 100mg, 1 or 2 times a day, the maximum dose of 400mg a day.
  (2) Anti-virus, 200mg once a day, once a day or 100mg once a day, once every 12 hours.
  2. Children
  (1) 1 to 9 years old children by weight once 1.5 ~ 3mg / kg, once every 8 hours, or once 2.2 ~ 4.4mg / kg, once every 12 hours.
  (2) Children aged 9 to 12 years old, 100 mg every 12 hours.
  (3) 12 years old and older, the same amount as adults.
  Amantadine hydrochloride capsule: administered orally.
  Adult
  (1) Parkinson's disease, Parkinson's syndrome, once 100mg, 1 or 2 times a day, the maximum dose of 400mg a day.
  (2) Anti-virus, 200mg once a day, once a day or 100mg once a day, once every 12 hours.
  2. Children
  (1) 1 to 9 years old children by weight once 1.5 ~ 3mg / kg, once every 8 hours, or once 2.2 ~ 4.4mg / kg, once every 12 hours.
  (2) Children aged 9 to 12 years old, 100 mg every 12 hours.
  (3) 12 years old and older, the same amount as adults.
  Amantadine hydrochloride granules: warm boiled water. Children aged 1 to 9 years old take 1.5 to 3 mg/kg every 8 hours, the daily dose does not exceed 150 mg; children over 9 years old are 100 mg once every 12 hours.
  Compound amantadine hydrochloride tablets: Oral, 1 tablet at a time, 2 times a day, 1 tablet each morning and evening, children reduce. Can be used for 3-5 days, up to 10 days.
  Compound amantadine aminopyrine tablets: oral. 1 tablet at a time, 2 times a day.

  [Storage]
  Amantadine hydrochloride tablets: shading, sealed and preserved.
  Amantadine hydrochloride capsule: protected from light and sealed.
  Amantadine hydrochloride granules: shading, sealed storage.
  Compound amantadine hydrochloride tablets: shading, sealed and preserved.
  Compound amantadine aminopyrine tablets: shading, sealed and preserved.

  [Tips] Some of the information on this site comes from the Internet and is only used internally by pharmacists or medical staff. It is not a substitute for doctors to diagnose face to face. Please consult a professional pharmacist for specific medications. Please refer to the actual product manual or the actual product for the product content.
• 

  Familial spastic paraplegia

  Oxibutin

  【Product name】Oxytrol, DITROPAN

  [English common name]Oxybutynin

  [Chinese common name]Oxibutin

  [English name]Oxibutynin

  [Chinese other name]Hydroxybutynin

  [indications]
  Oxybutynin hydrochloride sustained-release capsule: antispasmodic drug. For the treatment of acute (tight) forced urinary incontinence, urgency, frequent urination and other symptomsOveractive bladder(OAB) is also indicated for the treatment of neurogenic detrusor hyperactivity (eg caused by spina bifida) in children 6 years of age and older.
  Oxybutynin hydrochloride oral solution: for the relief of symptoms associated with urination in patients with non-inhibitory and reflux neurogenic bladder dysfunction, such as urgency, frequent urination, urinary incontinence, nocturia and enuresis.
  Oxybutynin hydrochloride sustained-release tablets: antispasmodic drugs. It is used to treat overactive bladder (OAB) with symptoms such as acute (tight) urge incontinence, urgency, and frequent urination.
  Oxybutynin hydrochloride capsule: This product is an antispasmodic drug for patients with non-inhibitory and reflux neurogenic bladder dysfunction and symptom relief associated with urination, such as urgency, frequent urination, urinary incontinence, nocturia and enuresis Wait.
  Oxybutynin hydrochloride tablets: This product is an antispasmodic drug for patients with non-inhibitory and reflux neurogenic bladder dysfunction and symptom relief associated with urination, such as urgency, frequent urination, urinary incontinence, nocturia and enuresis Wait.

  【Dosage】
  Oxybutynin hydrochloride sustained-release capsules:
  1. Adult: The initial dose is recommended to be 5-10mg once a day, then gradually increase the dose according to the efficacy and tolerance, each time increase 5mg, the maximum dose is 30mg / day, the dose adjustment generally takes about one week interval. Children over 2.6 years old: The initial recommended dose is 5mg once a day, then gradually increase the dose according to the efficacy and tolerance, each time increase 5mg, the maximum dose is 20mg / day. This product needs to be swallowed with liquid and cannot be chewed or crushed.
  Oxybutynin hydrochloride oral solution:
  1. The usual oral dose for adults is 5ml (5mg with oxybutynin hydrochloride), 2 to 3 times a day; the maximum dose is 5ml (5mg with oxybutynin hydrochloride), 4 times a day. Or follow the doctor's advice.
  Oral dosage of children over 2.5 years old, 5ml at a time (5mg with oxybutynin hydrochloride), 2 times a day; maximum dose, 5ml at a time (5mg with oxybutynin hydrochloride), 3 times a day. Or follow the doctor's advice.
  The clinical data of children under 3.5 years of age is insufficient and is not recommended. The cap can be used for measuring cups, each cover to the engraved line 5ml.
  Oxybutynin hydrochloride sustained-release tablets: The initial recommended dose is once a day, 5mg (half tablet), and then gradually increase the dose according to the efficacy and tolerance, each time increase 5mg, the maximum dose is 30mg / day, or as directed Children are reduced. This product needs to be swallowed with liquid, can not be chewed or crushed, but can be taken according to the half line.
  Oxybutynin hydrochloride capsules: The usual dosage for oral administration in adults is 5 mg (1 capsule) once a day, 2 to 3 times a day; the maximum dose is 5 mg (1 capsule) at a time, 4 times a day. Or follow the doctor's advice. Oral dosage of children over 5 years old, 5mg (1 capsule) at a time, 2 times a day; maximum dose, 5mg (1 capsule) at a time, 3 times a day. Or follow the doctor's advice. The clinical data of children under 5 years of age is insufficient and is not recommended.
  Oxybutynin hydrochloride tablets: The usual dosage for oral administration in adults is 5 mg once a day, 2 to 3 times a day; the maximum dose is 5 mg once a day, 4 times a day. Or follow the doctor's advice. Oral dosage of children over 5 years old, 5mg once, 2 times a day; maximum dose, 5mg once, 3 times a day. Or follow the doctor's advice. The clinical data of children under 5 years of age is insufficient and is not recommended.

  [Storage]
  Oxybutynin hydrochloride sustained-release capsule: sealed and placed in a cool place.
  Oxybutynin hydrochloride oral solution: sealed, placed in a cool place.
  Oxybutynin hydrochloride sustained-release tablets: shading, confined preservation.
  Oxybutynin hydrochloride capsules: shading, sealed, kept in a cool dry place.
  Oxybutynin hydrochloride tablets: shading, sealed, kept in a cool dry place.

  [Tips] Some of the information on this site comes from the Internet and is only used internally by pharmacists or medical staff. It is not a substitute for doctors to diagnose face to face. Please consult a professional pharmacist for specific medications. Please refer to the actual product manual or the actual product for the product content.
• 

  Familial spastic paraplegia

  Botulinum toxin

  【Product name】XEOMIN

  [English common name]incobotulinumtoxinA

  [Chinese common name]Botulinum toxin

  [English name]BTX, Botulinum Toxin

  [Chinese other name]Net good, angel bot

  [Indications] Eyelids, hemifacial spasms and related disorders of dystonia.

  [Usage and Dosage] The recommended dose of this product should not be interchanged with the dose of other Clostridium botulinum toxin preparations. This product must be used by a physician with appropriate qualifications and experience in treatment, and with appropriate equipment. The optimal effective dose and the optimal number of injection sites per muscle have not yet been established, so individual treatment regimens should be developed by the physician and the optimal dose should be determined by titration. Ailigen will assist in the training of this product injection technology. The recommended dose range for each injection site is 0.05-0.1 ml (eyelid, hemifacial spasm). See the following dilution table. Injection of this product with a sterile, 27-30/0.40-0.30mm needle does not necessarily require EMG monitoring. The recommended initial injection dose for the lateral part of the medial and lateral parts of the upper orbital iliac muscle of the upper eyelid iliac muscle is 1.25-2.5 U. If the eyebrows, the lateral aspect of the orbicularis and the upper facial area affect visual acuity, the injection site should also be increased at the corresponding site. Avoiding injections close to the upper eyelid side can reduce complications of drooping eyelids. Avoid the injection of the inside of the lower eyelid to reduce the spread of the oblique muscle, which can reduce the complications of double vision. The lower icon shows the injection reference site: it takes effect within three days after the general injection and reaches a peak in 1-2 weeks. Each treatment lasts for approximately 3 months and can be repeated as needed. When repeating treatment, if the initial therapeutic dose is considered insufficient, the injected dose can be increased or even doubled. However, if an injection site dose exceeds 5.0 U, there will be no better effect. The initial therapeutic dose per eye should not exceed 25U. In general, treatment frequencies greater than once every 3 months are not beneficial to the patient. When treating eyelids, the total dose per 12 weeks should not exceed 100U. Hemifacial spasm and VII pairs of patients with abnormal brain function, treatment of patients with unilateral orbital, and other affected facial muscles can be injected as needed. If the first treatment fails, ie one month after the injection, there is no significant clinical improvement compared to before treatment, the following measures should be taken: • Clinical validation, including specialists performing an EMG examination of the blockade of injected muscle; • Analysis failure Causes such as: improper selection of injected muscles, insufficient injection dose, lack of injection technique, occurrence of fixed muscle contracture, antagonism of muscle weakness, neutralization of toxin antibody formation, etc.; • Re-evaluation of treatment with Clostridium botulinum toxin type A; • If the first treatment is not effective, the following measures can be taken for the second treatment:
  (1) Analyze the cause of the first treatment failure and adjust the dose;
  (2) Injection under EMG monitoring;
  (3) There is a three-month interval between the two treatments. If the reinjection treatment fails or is not effective, consider replacing the treatment. How to use, handle and dispose of this product: It is recommended to carry out the dilution operation and the preparation of the syringe on the paper towel with plastic liner to prevent the liquid from splashing. The product was diluted with sterile, preservative-free saline (0.9% sodium chloride for injection). Draw the appropriate amount of diluent with a syringe (see the dilution table below). Since the product will be denatured by the vibration of bubbles or similar forces, the diluent should be gently pushed into the bottle. If there is no vacuum suction in the bottle, the bottle should be discarded. After preparation, this product should be a clear liquid with no color to slightly yellow and no impurities. Before using the preparation solution, visually check the clarity and impurities. The preparation solution should be stored in the refrigerator (2 ° C - 8 ° C) for up to 4 hours. This product can only be used in a single use, and the remaining solution should be discarded. For safety reasons, unused vials should be filled with a small amount of water and then autoclaved; all used vials, syringes, and spilled liquids should be autoclaved or 0.5% hypochlorous acid. The salt solution inactivated the residue of the product for 5 minutes.

  [Storage] Store at 2oC~8oC in cold storage or below -5oC. After preparation: Store at 2oC~8oC in cold storage and use within 4 hours. Container: A 10 ml capacity type I colorless glass bottle with a rubber stopper and sealed with aluminum foil.

  [Tips] Some of the information on this site comes from the Internet and is only used internally by pharmacists or medical staff. It is not a substitute for doctors to diagnose face to face. Please consult a professional pharmacist for specific medications. Please refer to the actual product manual or the actual product for the product content.